Preliminary data regarding the use of radioligand therapy using PSMA for treatment of ccRCC show early potential, although rapid radiotracer washout from ccRCC lesions appears to limit therapeutic efficacy [25]. Here, FOLH1 is linked to nonpapillary renal cell carcinoma.